Related Experiment Video
Updated: Mar 26, 2026

Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
New radiotracers in gynecological cancer: beyond ¹⁸F-FDG
1Department of Clinical Oncology, Bristol Cancer Institute, Bristol, UK - amarnath.challapalli@uhbristol.nhs.uk.
Abstract:
Imaging plays an important role in the management of gynecological cancers. There is a clinical need for noninvasive prognostic biomarkers to provide more detailed tumor characterization at the baseline and/or early during therapy, which may potentially improve outcomes and enable a personalized treatment approach. Imaging parameters derived from PET/CT techniques are emerging as promising imaging biomarkers. This review details the current evidence and future potential of functional imaging using non-2-deoxy-2-[18F]fluoro-D-glucose (FDG) tracers in gynecological cancers.
More Related Videos
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

